Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations - Archive ouverte HAL Access content directly
Journal Articles Journal of Investigative Dermatology Year : 2021

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

, , , , (1, 2) , , , , , , ,
1
2
Florence Le Duff
Jean-David Bouaziz
Eric Fontas
Michel Ticchioni
Olivier Dereure
Pascal Reygagne
Henri Montaudié
Jean-Philippe Lacour
Sandrine Monestier
Marie-Aleth Richard
Thierry Passeron

Dates and versions

hal-03425030 , version 1 (12-11-2021)

Identifiers

Cite

Florence Le Duff, Jean-David Bouaziz, Eric Fontas, Michel Ticchioni, Manuelle Viguier, et al.. Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations. Journal of Investigative Dermatology, 2021, 141 (4), pp.933 - 936.e6. ⟨10.1016/j.jid.2020.08.015⟩. ⟨hal-03425030⟩

Collections

URCA IRMAIC
10 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More